EVO Evotec SE

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · evotec.com

1.610USD-1.23%Mkt Cap: 572.18M $P/E: —1d ago

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just Evotec Biolog…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited

$58.68BUSD

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB (publ)

$14.43BUSDP/E 112.9

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporated

$11.17BUSD

RDY

Dr. Reddy's Laboratories Limited

Hims & Hers Health, Inc.

$6.89BUSD

AMRX

Amneal Pharmaceuticals, Inc.

$6.84BUSDP/E 40.1

Key Statistics

Company

Market Cap572.18M USD

Enterprise Value589.50M USD

Revenue (TTM)717.28M USD

Gross Profit114.22M USD

Net Income (TTM)-103.52M USD

Revenue/Share2.02 USD

Last Price1.610 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees4.5K

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-8.58

PEG1.42

EV/EBITDA-8.05

EV/Revenue0.82

P/S0.81

P/B0.77

EPS (TTM)-0.63

EPS (Forward)-0.19

52W Range

1.5004% of range4.270

52W High4.270 USD

52W Low1.500 USD

Profitability

Gross Margin14.49%

Oper. Margin-62.26%

EBITDA Margin-10.20%

Profit Margin-13.13%

ROE-12.72%

ROA-6.04%

Growth

Revenue Growth-16.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-9.18M USD

CapEx (TTM)82.62M USD

FCF Margin-11.29%

FCF Yield-14.15%

Net Debt10.28M USD

Net Debt/EBITDA-0.14

Balance Sheet

Debt/Equity0.55

Current Ratio2.33

Quick Ratio2.02

Book Value/Sh2.11 USD

Cash/Share1.31 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split4:1

Split DateOct 20, 2021

Analyst Consensus

Rating—

Target (Mean)4.175 USD

Upside (mean)+159.3%

Target Range1.948 USD – 6.680 USD

1.948+159.3% to mean6.680

# Analysts3

Ownership

Shares Out.355.39M

Float270.98M

Insiders0.01%

Institutions0.81%

Short Interest

Short Ratio2.1d

Short % Float0.03%

Short % Out.0.03%

Shares Short102.49K

Short (prev mo.)50.74K

Technical

SMA 501.823 (-11.7%)

SMA 2002.684 (-40.0%)

Beta1.27

S&P 52W Chg16.45%

Avg Vol (30d)136.89K

Avg Vol (10d)117.86K

Technical Indicators

RSI (14)40.9

MACD-0.0721

MACD Signal-0.0903

MACD Hist.+0.0182

BB Upper1.817 USD

BB Middle1.644 USD

BB Lower1.471 USD

BB Width21.03%

ATR (14)0.0730 USD

Vol Ratio (20d)0.52x